|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||
| Share-based compensation expense | |||||
| Depreciation and amortization | |||||
| Goodwill impairment | |||||
| Deferred debt issuance and discount expense | |||||
| Gain on extinguishment of convertible debt | |||||
| Provision for credit losses | |||||
| Deferred income taxes | |||||
| Fair value changes in loans held for investment | |||||
| Fair value changes in residual interests classified as debt | |||||
| Fair value changes in securitization investments | |||||
| Fair value changes in warrant liabilities | |||||
| Equity method investment earnings | |||||
| Other | |||||
| Changes in loans held for sale, net | |||||
| Changes in accrued interest on loans | |||||
| Changes in loans previously classified as held for sale, net | |||||
| Changes in servicing assets | |||||
| Changes in other assets | |||||
| Related party notes receivable interest income | |||||
| Changes in other liabilities | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Purchases of property, equipment and software | |||||
| Capitalized software development costs | |||||
| Purchases of available-for-sale investments | |||||
| Proceeds from sales of available-for-sale investments | |||||
| Proceeds from maturities and paydowns of available-for-sale investments | |||||
| Purchases of loans held for investment | |||||
| Proceeds from sales of loans held for investment | |||||
| Other changes in loans held for investment, net | |||||
| Proceeds from securitization investments | |||||
| Proceeds from non-securitization investments | |||||
| Purchases of non-securitization investments | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Proceeds from repayment of related party notes receivable | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Net change in deposits | |||||
| Proceeds from issuance of common stock | |||||
| Payment of common stock issuance costs | |||||
| Net change in debt facilities | |||||
| Proceeds from other debt issuances | |||||
| Repayment of other debt | |||||
| Payment of debt issuance costs | |||||
| Purchase of capped calls | |||||
| Unwind of capped calls | |||||
| Taxes paid related to net share settlement of share-based awards | |||||
| Proceeds from stock option exercises | |||||
| Proceeds from issuance of common stock under the ESPP | |||||
| Payment of redeemable preferred stock dividends | |||||
| Redemption of Series 1 preferred stock | |||||
| Finance lease principal payments | |||||
| Purchases of common stock | |||||
| Redemptions of redeemable common and preferred stock | |||||
| Proceeds from Business Combination and PIPE Investment | |||||
| Payment of costs directly attributable to the issuance of common stock in connection with Business Combination and PIPE Investment | |||||
| Proceeds from warrant exercises | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents | |||||
| Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period | |||||
| Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | |||||
| Supplemental cash flow information | |||||
| Interest paid | |||||
| Income taxes paid, net | |||||
| Supplemental non-cash investing and financing activities | |||||
| Deposits credited but not yet received in cash | |||||
| Deconsolidation of securitization and residual debt | |||||
| Extinguishment of convertible notes by issuance of common stock | |||||
| Securitization investments acquired via loan transfers | |||||
| Share-based compensation capitalized related to internally-developed software | |||||
| Finance lease right-of-use assets acquired | |||||
| Derecognition of securitization investments | |||||
| Deposits assumed in acquisition | |||||
| Loans held for investment received in acquisition | |||||
| Available-for-sale securities received in acquisition | |||||
| Reconciliation to amounts on consolidated balance sheets (as of period end) | |||||
| Cash and cash equivalents | |||||
| Restricted cash and restricted cash equivalents | |||||
Loading...